Page last updated: 2024-12-05

octamethyl pyrophosphoramide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

octamethyl pyrophosphoramide: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9037
CHEBI ID82148
SCHEMBL ID120233
MeSH IDM0052793

Synonyms (81)

Synonym
oktamethyl [czech]
bis(bisdimethylaminophosphonous) anhydride
brn 1801375
octamidophos
einecs 205-801-0
pestox 66
ai3-17291
rcra waste number p085
bis(bisdimethylaminophosphonous)anhydride
bis-n,n,n',n'-tetramethylphosphorodiamidic anhydride
octamethyl-difosforzuur-tetramide [dutch]
ottometil-pirofosforammide [italian]
hsdb 1744
schradane [french]
oktamidofos [czech]
rcra waste no. p085
nsc 8929
pyrophosphoric acid octamethyltetraamide
octamethyl pyrophosphoramide
ent 17,291
schradan [iso]
caswell no. 610
octamethyl-diphosphorsaeure-tetramid [german]
epa pesticide chemical code 058601
schradane
152-16-9
pestox-3
octamethyldiphosphoramide
octamethylpyrophosphoric acid amide
ompacide
wln: 1n1 & po & n1 & 1 & opo & n1 & 1 & n1 & 1
octamethyl tetramido pyrophosphate
systam
nsc8929
sytam
ompa
nsc-8929
schradan
octamethyl
pestox iii
pyrophosphoramide, octamethyl-
ompax
lethalaire g-59
octamethylpyrophosphoric acid tetramide
systophos
bis-n,n',n'-tetramethylphosphorodiamidic anhydride
pestox
octamethylpyrophosphoramide
pyrophosphoryltetrakisdimethylamide
diphosphoramide, octamethyl-
octamethyl pyrophosphortetramide
pyrophosphoric acid, octamethyltetraamide
ottometil-pirofosforammide
octamethyl-diphosphorsaeure-tetramid
bis(dimethylamino)phosphoric anhydride
ompatox
pestox 3
tetrakisdimethylaminophosphonous anhydride
octamethyl-difosforzuur-tetramide
bis(dimethylamino)phosphonous anhydride
n-[bis(dimethylamino)phosphoryloxy-(dimethylamino)phosphoryl]-n-methyl-methanamine
bis-n,n,n', n'-tetramethylphosphorodiamidic anhydride
n-[bis(dimethylamino)phosphoryloxy-(dimethylamino)phosphoryl]-n-methylmethanamine
oktamidofos
4-04-00-00288 (beilstein handbook reference)
d77oym46s1 ,
unii-d77oym46s1
diphosphoramide, n,n,n',n',n'',n'',n''',n'''-octamethyl-
oktamethyl
C19015
schradan [hsdb]
schradan [mi]
octamethylpyrophosphoric tetraamide
SCHEMBL120233
CHEBI:82148
SZKKRCSOSQAJDE-UHFFFAOYSA-N
DTXSID0042373
schradan 100 microg/ml in acetonitrile
Q27155770
diphosphoric acid tetrakis-dimethylamide
schradan 1000 microg/ml in acetone

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The animals tolerated an accumulated 6-fold LD50 dose and survived an LD90 dose of carbachol, indicating tolerance to this cholinergic agonist."( Different role of carboxylesterases in toxicity and tolerance to paraoxon and DFP.
Dettbarn, WD; Milatovic, D; Yang, ZP, 1999
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
phosphorodiamide
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (39)

TimeframeStudies, This Drug (%)All Drugs %
pre-199030 (76.92)18.7374
1990's8 (20.51)18.2507
2000's1 (2.56)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 15.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index15.47 (24.57)
Research Supply Index3.69 (2.92)
Research Growth Index3.97 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (15.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other39 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]